6X78
Vaccine-elicited mouse FP-targeting neutralizing antibody vFP48.03 in complex with HIV fusion peptide (residue 512-519)
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | APS BEAMLINE 22-ID |
| Synchrotron site | APS |
| Beamline | 22-ID |
| Temperature [K] | 100 |
| Detector technology | PIXEL |
| Collection date | 2019-11-20 |
| Detector | DECTRIS EIGER X 16M |
| Wavelength(s) | 1 |
| Spacegroup name | P 21 21 21 |
| Unit cell lengths | 81.993, 92.733, 143.424 |
| Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
| Resolution | 38.937 - 2.359 |
| R-factor | 0.1802 |
| Rwork | 0.178 |
| R-free | 0.22600 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Starting model (for MR) | 6cdo |
| Data reduction software | HKL-2000 |
| Data scaling software | HKL-2000 |
| Phasing software | PHASER |
| Refinement software | PHENIX (1.14_3260) |
Data quality characteristics
| Overall | Inner shell | Outer shell | |
| Low resolution limit [Å] | 50.000 | 50.000 | 2.400 |
| High resolution limit [Å] | 2.359 | 6.400 | 2.360 |
| Rmerge | 0.145 | 0.049 | 0.746 |
| Rmeas | 0.157 | 0.054 | 0.817 |
| Rpim | 0.061 | 0.021 | 0.327 |
| Number of reflections | 45627 | 2479 | 2243 |
| <I/σ(I)> | 5.5 | ||
| Completeness [%] | 99.7 | 99.5 | 100 |
| Redundancy | 6.6 | 6.1 | 6.1 |
| CC(1/2) | 0.998 | 0.810 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, SITTING DROP | 8.5 | 295 | 0.1 M Tris, pH 8.5, 25% w/v PEG3350 |






